8-K: Evolv Technology Announces Restatement Completion, Reports Positive Adjusted EBITDA for Q4 2024

Sentiment:

Earnings Release


Evolv Technology completes its financial restatement, regains compliance with SEC and NASDAQ, and reports positive adjusted EBITDA for the fourth quarter of 2024.

Delay expectedThe company had to restate its financial statements due to inaccurate accounting practices, which delayed the release of financial results.
Better than expectedThe company achieved positive Adjusted EBITDA in Q4 2024, which was ahead of schedule.Revenue and ARR showed significant year-over-year growth in Q4 2024.Net loss for the twelve months ended December 31, 2024 decreased compared to the prior year.

Summary

  • Evolv Technology has completed the restatement of its previously issued financial statements.
  • The company has filed its 2024 Annual Report on Form 10-K with the SEC.
  • The restatements correct inaccurate accounting for certain sales transactions, leading to premature or incorrectly recognized revenue of approximately $3.1 million from Q2 2022 through Q2 2024.
  • Evolv Technology has regained compliance with SEC reporting and NASDAQ listing requirements.
  • Q4 2024 revenue was $29.1 million, up 41% year-over-year.
  • The company achieved positive Adjusted EBITDA of $0.4 million in Q4 2024.
  • Ending ARR for Q4 2024 was $99.4 million, up 39% year-over-year.
  • Ending RPO for Q4 2024 was $266.7 million.
  • Total revenue for the third quarter of 2024 was $27.4 million, an increase of 37% compared to $20.0 million (as restated) for the third quarter of 2023.
  • Net loss for the third quarter of 2024 was $(30.4) million, or $(0.19) per basic and diluted share, compared to net income of $5.0 million (as restated), or $0.03 (as restated) per basic and diluted share, in the third quarter of 2023.
  • Adjusted EBITDA for the third quarter of 2024 was $(3.0) million compared to $(11.6) million (as restated) in the third quarter of 2023.
  • As of September 30, 2024, the Company had cash, cash equivalents, marketable securities, and restricted cash of $56.3 million and no debt.
  • Total revenue for the twelve months ended December 31, 2024 was $103.9 million, an increase of 31% compared to $79.6 million (as restated) for the twelve months ended December 31, 2023.
  • Net loss for the twelve months ended December 31, 2024 was $(54.0) million, or $(0.34) per basic and diluted share, compared to $(108.0) million (as restated), or $(0.72) (as restated) per basic and diluted share, in the twelve months ended December 31, 2023.
  • As of December 31, 2024, the Company had cash, cash equivalents, marketable securities, and restricted cash of $51.9 million and no debt.
  • The Company had approximately 6,100 units deployed as of December 31, 2024, reflecting a one time adjustment to remove approximately (100) non-revenue generating units from the Company's deployed unit count related to Evolv Edge, the Company's first generation product offering.

Sentiment

Score: 7

Explanation: The sentiment is cautiously positive. While the restatement was a setback, the company has addressed the issues, regained compliance, and achieved positive Adjusted EBITDA. The growth in revenue and ARR is encouraging, but the past losses and ongoing risks warrant a moderate assessment.

Positives

  • The company has completed its financial restatement and is now compliant with SEC and NASDAQ requirements.
  • Evolv achieved positive Adjusted EBITDA in Q4 2024, indicating improved profitability.
  • Revenue and ARR showed significant year-over-year growth in Q4 2024.
  • The company has a strong RPO, suggesting future revenue visibility.
  • Evolv has a healthy cash balance with no debt.
  • Total revenue for the twelve months ended December 31, 2024 increased by 31% compared to the prior year.
  • Net loss for the twelve months ended December 31, 2024 decreased compared to the prior year.

Negatives

  • The company had to restate its financial statements due to inaccurate accounting practices.
  • The restatement resulted from premature or incorrect revenue recognition of $3.1 million from Q2 2022 through Q2 2024.
  • The company reported a net loss for the third quarter of 2024 of $(30.4) million.
  • The company reported a net loss for the fourth quarter of 2024 of $(15.7) million.
  • The company reported a net loss for the twelve months ended December 31, 2024 of $(54.0) million.

Risks

  • The company's future performance depends on disciplined execution, transparent communication, and compliance.
  • The company's ability to maintain competitiveness in the security technology market is crucial.
  • The company's reliance on reseller partners to generate a growing portion of its revenue.
  • The company's reliance on third party contract manufacturing and distribution, and a global supply chain.
  • The company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results.
  • The company's ability to obtain, maintain, protect and enforce its intellectual property rights and use of open source software.
  • The concentration of the Company's revenues on a single solution.
  • The Company's ability to timely design, produce and launch its solutions, the Companys ability to invest in growth initiatives and pursue acquisition opportunities.
  • The limited liquidity and trading of the Companys securities.
  • Risks related to existing and changing tax laws.
  • Geopolitical risk and changes in applicable laws or regulations.
  • The possibility that the Company may be adversely affected by other economic, business, and/or competitive factors.
  • Operational risk.
  • Risks related to material weaknesses in our internal control over financial reporting and our remediation plans.
  • Risks related to increasing attention to and evolving expectations for, environmental, social, and governance initiatives.
  • The impact of fluctuating general economic and market conditions and reductions in spending.
  • The need for additional capital to support business growth, which might not be available on acceptable terms, if at all.
  • Litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources.

Future Outlook

The company is focused on disciplined execution, transparent communication, and compliance, believing it is well-positioned for its next phase of growth and to lead the transformation of the security technology landscape.

Management Comments

  • Completing this restatementwhich brings the Company back into full compliance with SEC reporting and Nasdaq listing requirementsmarks an important milestone in our ongoing work to rebuild stakeholder confidence, said John Kedzierski, President and Chief Executive Officer of Evolv Technology, Inc.
  • Looking ahead, we are focused on prioritizing disciplined execution, transparent communication, and an unwavering commitment to best-in-class compliance.
  • With both the restatement and the FTC resolution now firmly behind us and having achieved our long-standing profitability goals six months ahead of schedule, we believe we are well-positioned as we enter our next phase of growth.
  • We are poised to lead the transformation of the security technology landscapemaking the world a safer place where people can live, work, learn, and play.

Industry Context

Evolv Technology operates in the security technology sector, providing AI-based screening solutions. The announcement highlights the company's efforts to regain investor confidence after a period of financial restatement, which is crucial for maintaining its competitive position and attracting investment in a rapidly evolving market.

Comparison to Industry Standards

  • It is difficult to compare Evolv directly to industry standards without knowing the specific benchmarks for AI-based security screening solutions.
  • However, achieving positive Adjusted EBITDA is a significant milestone, as many growth-stage technology companies struggle with profitability.
  • Companies like Motorola Solutions and FLIR Systems operate in broader security technology markets, but their business models and product offerings differ significantly from Evolv's.
  • Evolv's growth rates in revenue and ARR should be compared to those of other companies in the AI-powered security screening space to assess its relative performance.

Stakeholder Impact

  • Shareholders: The completion of the restatement and return to compliance should reassure investors.
  • Employees: The company's focus on execution and growth could create opportunities for employees.
  • Customers: The company's commitment to security technology aims to provide safer experiences for customers.
  • Suppliers: The company's growth could lead to increased demand for suppliers.
  • Creditors: The company's healthy cash balance and lack of debt should be reassuring to creditors.

Key Dates

DateDescription
2019Evolv's advanced systems have scanned more than two billion people since 2019.
Second quarter of 2022 through the second quarter of 2024The errors resulted in premature or incorrect recognition of approximately $3.1 million of revenue on a net basis from the second quarter of 2022 through the second quarter of 2024.
September 30, 2024Date of Quarterly Report on Form 10-Q filed with the SEC.
December 31, 2024Date of Annual Report on Form 10-K filed with the SEC.
April 28, 2025Date of report (Date of earliest event reported): Filing of Form 8-K, 10-Q, and 10-K.

Keywords

Evolv Technology, Financial Results, Restatement, Adjusted EBITDA, ARR, RPO, Revenue, Security Technology, AI, Compliance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.